HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Intrauterine therapy for nonimmune hydrops fetalis (NIHF)--analysis of 38 cases].

AbstractOBJECTIVE:
The aim of the study was to perform an audit the results of fetal therapy in cases of nonimmune hydrops fetalis (NIHF), isolated hydrothorax and isolated ascites.
METHODS:
A total of 38 fetuses (17-35 weeks of pregnancy) were included in the study whereas 6 patients were excluded due to abnormal karyotype. NIHF was diagnosed in 24 cases, hydrothorax in 4 cases, and ascites in 4 cases. Shunts were implanted in 26 (81%) cases and 7 (19%) participants underwent therapeutic cordocentesis.
RESULTS:
After therapy anterior-posterior diameter of the right and the left lung increased to 9.6 mm (27%) and 12.4 mm (35%), respectively. Early complications were observed in 5 (16%) cases. PROM 2 (40%), fetal death 1 (20%), infection 1 (20%), and preterm delivery 1 (20%). Out of the 27 patients, 65% had a caesarian section without early complications and 35% had a vaginal delivery with 58% at term and 42% pre-term.
CONCLUSIONS:
Preceding results show that intrauterine therapy significantly improves prognosis of fetuses with NIHF.
AuthorsKamila Sobczuk, Justyna Wojtera, Ewa Draga, Ewa Gulczyńska, Katarzyna Janiak, Krzysztof Szaflik
JournalGinekologia polska (Ginekol Pol) Vol. 85 Issue 2 Pg. 92-100 (Feb 2014) ISSN: 0017-0011 [Print] Poland
Vernacular TitleTerapia wewnatrzmaciczna w nieimmunologicznym obrzeku płodu (NIHF)--analiza 38 przypadków.
PMID24745153 (Publication Type: English Abstract, Journal Article)
Topics
  • Cordocentesis (methods)
  • Drainage (methods)
  • Female
  • Humans
  • Hydrops Fetalis (surgery)
  • Hydrothorax (etiology, surgery)
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy, High-Risk
  • Prenatal Care (methods)
  • Ultrasonography, Prenatal

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: